BELLUS Health Statistics Share Statistics BELLUS Health has 126.81M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 126.81M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 92.13M Failed to Deliver (FTD) Shares 166,000 FTD / Avg. Volume 3.08%
Short Selling Information The latest short interest is 6.65M, so 5.24% of the outstanding
shares have been sold short.
Short Interest 6.65M Short % of Shares Out 5.24% Short % of Float n/a Short Ratio (days to cover) 2.58
Valuation Ratios The PE ratio is -12.46 and the forward
PE ratio is null.
BELLUS Health's PEG ratio is
0.47.
PE Ratio -12.46 Forward PE n/a PS Ratio 59265.57 Forward PS n/a PB Ratio 2.43 P/FCF Ratio -9.68 PEG Ratio 0.47
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BELLUS Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 22.42,
with a Debt / Equity ratio of 0.
Current Ratio 22.42 Quick Ratio 22.42 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.01 Interest Coverage -998.5
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $216.22 Profits Per Employee $-1.03M Employee Count 74 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 60K Effective Tax Rate -0.08%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.28, so BELLUS Health's
price volatility has been lower than the market average.
Beta -0.28 52-Week Price Change n/a 50-Day Moving Average 14.55 200-Day Moving Average 10.13 Relative Strength Index (RSI) 78.88 Average Volume (20 Days) 5,381,551
Income Statement In the last 12 months, BELLUS Health had revenue of 16K
and earned -76.08M
in profits. Earnings per share was -0.66.
Revenue 16K Gross Profit -3.51B Operating Income -77.88M Net Income -76.08M EBITDA -72.76M EBIT -75.94M Earnings Per Share (EPS) -0.66
Full Income Statement Balance Sheet The company has 87.25M in cash and 1.28M in
debt, giving a net cash position of 85.97M.
Cash & Cash Equivalents 87.25M Total Debt 1.28M Net Cash 85.97M Retained Earnings -641.84M Total Assets 3.09B Working Capital 890.08M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -77.1M
and capital expenditures -20.89M, giving a free cash flow of -97.98M.
Operating Cash Flow -77.1M Capital Expenditures -20.89M Free Cash Flow -97.98M FCF Per Share -0.85
Full Cash Flow Statement Margins Gross margin is -21967104.08%, with operating and profit margins of -486768.75% and -475500%.
Gross Margin -21967104.08% Operating Margin -486768.75% Pretax Margin -475125% Profit Margin -475500% EBITDA Margin -454768.75% EBIT Margin -486768.75% FCF Margin -612387.7%
Dividends & Yields BLU does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BLU.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 19, 2019. It was a
backward
split with a ratio of 5:18.
Last Split Date Aug 19, 2019 Split Type backward Split Ratio 5:18
Scores Altman Z-Score 1.12 Piotroski F-Score 3
